The IJCMG accepts the following manuscript types:
- Research Articles: original research. The text for research articles is limited to 6,000 words including the title page, abstract, text, references, figures, and tables.
- Review Articles: The article type should provide a comprehensive and relevant analysis of a particular subject. Review articles are often requested by the editors, although unsolicited submissions may also be taken into consideration. In order to submit a review article, authors are required to send an email to the Editor-in-Chief at [email protected], with the subject line labeled as "Request to send a review for IJCMG". In addition, the author is required to elucidate their intention and provide corroborating evidence of their expertise in the respective field. The individual's request will undergo an evaluation process, and they will thereafter receive notification of the outcome of the editorial assessment. They can then proceed accordingly based on this information.
- Systematic Review and Meta-analysis: A systematic review is a rigorous research method that aims to address a specific research topic by systematically gathering and analyzing all relevant empirical material that meets predetermined eligibility criteria. Meta-analysis refers to the application of statistical techniques in order to synthesize and summarize the findings of several investigations.
- Methodological papers: We invite manuscripts that encompass a comprehensive account of innovative methodologies and substantial enhancements to established fundamental research approaches pertaining to the field of cancer or medical genetics. The manuscript aims to provide readers with novel tools and abilities that can enhance their approach and facilitate their research endeavors.
- Editorials: The perspectives of respected authorities in the field of cancer or medical genetics specialty. Editorials are typically requested by the Editor-in-Chief and pertain to a manuscript inside the same issue. The maximum word count for the document should not surpass 3000 words, and the number of references should not exceed 30.
- Commentaries: This text presents an opinion that is of broad relevance, but it is not directly connected to any specific article within the same issue of the (IJCMG).
- Short Communications: This scientific paper focuses on chosen subjects derived from reputable cancer groups or societies. The short communication presents scientific findings in a style that is more abstract and descriptive. Short communications should primarily focus on presenting completed work rather than preliminary findings. This style serves as an alternative means of describing smaller research endeavors. The format of the paper should adhere to the original framework, maintaining a maximum length of 2,500 words and include no more than two tables or figures. This can consist of either two figures, two tables, or one figure and one table. The word count of 2500 does not encompass the tables, abstract, and references. The number of references should be restricted to a maximum of 25.
- In Memoriam: Memorialization of recently deceased individuals who have made notable contributions to the field of cancer and medical genetics in Iraq and the Middle east region.
- Correspondence: Correspondence Addressed to the Editor Pertaining to Previously Published Papers in the Iraqi Journal of Cancer and Medical Genetics. The submission of letters is required to be completed within a time frame of six months from the date of online publication of the article. The authors of the original publication will be afforded the option to provide a response within the same issue of the journal. The length of letters and responses should not exceed 1000 words. It is imperative to disclose any financial affiliations or possible conflicts of interest.
- Case Report: Report of single case with significant value to the scientific community; however, the IJCMG encourages large case series from around the world about populations (minorities, ethnicities, and populations with a particular attribute), in which not much data on cancer or medical genetics are available.
- Protocol: Manuscripts pertaining to ongoing or commencing substantial, carefully designed investigations, such as clinical trials and cohorts, may be deemed suitable for publication provided that the submission adheres to the guidelines outlined in the Protocol Items for Randomized Trials (SPIRIT) framework. It is recommended that those considering writing visit the official SPIRIT website located at "http://www.spirit-statement.org" in order to familiarize themselves with the guidelines outlined in the convention. They should then proceed to create their book in accordance with the SPIRIT principles. The text ought to include all the elements specified in the SPIRTI checklist. In order to be deemed suitable for publishing, it is imperative that the protocol goes through the necessary ethical approval process and is legally registered, particularly in the context of clinical trials.